Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hartman

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 2, 2025
Pharmacological Inhibition of Ferroptosis Attenuates Experimental Abdominal Aortic Aneurysm FormationJonathan R Krebs, Paolo Bellotti, Walker Ueland, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's diseaseC P Smith, G M Bores, W Petko, et al.
Journal of Lipid Research|March 26, 2009
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseElaine M Quinet, Michael D Basso, Anita R Halpern, et al.
Clinical Spine Surgery|June 20, 2020
Processing and Handling Cost of Single-use Versus Traditional Instrumentation for 1 Level Lumbar FusionsMatthew S Galetta, Srikanth N Divi, Mark A Shapses, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 2, 2025
Pharmacological Inhibition of Ferroptosis Attenuates Experimental Abdominal Aortic Aneurysm FormationJonathan R Krebs, Paolo Bellotti, Walker Ueland, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's diseaseC P Smith, G M Bores, W Petko, et al.
Journal of Lipid Research|March 26, 2009
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseElaine M Quinet, Michael D Basso, Anita R Halpern, et al.
Clinical Spine Surgery|June 20, 2020
Processing and Handling Cost of Single-use Versus Traditional Instrumentation for 1 Level Lumbar FusionsMatthew S Galetta, Srikanth N Divi, Mark A Shapses, et al.
Pageof 14